1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Ain Holdings Inc.

Ain Holdings Inc.

9627.T
Ain Holdings Inc.JP flagTokyo Stock Exchange
5,723.00
JPY
-57.00
- -
200.98BMarket Cap
Ain Holdings Inc.
9627.T
(Tokyo Stock Exchange)

Recent

price

5,723.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
4,222.75
4,478.76
4,847.97
5,341.76
5,926.12
7,406.54
7,824.95
7,875.26
7,779.16
8,259.55
8,391.95
8,983.7
10,212.1
11,384.87
13,037.73
- -
5,890.46
Revenue per Share
127.84
153.67
159.19
165.04
195.45
249.69
250.71
310.07
254.86
259.09
189.03
201.46
262.86
324.64
264.32
- -
175.6
Basic EPS, GAAP
198.19
253.22
187.59
326.63
348.94
360.65
471.84
526.65
276.59
320.91
259.32
503.97
230.92
299.1
312.9
- -
- -
Free Cash Flow per Basic Share
18.41
22.5
25
30.01
30
30
40
46.51
49.99
54.99
54.99
55.34
55
60
80.66
- -
- -
Dividend per Share
715.07
818.95
953.14
1,088.6
1,271.7
1,491.4
1,702.11
2,234.83
2,354.67
2,558.8
2,692.83
2,856.49
3,070.3
3,335.84
3,527.29
- -
3,359.32
Book Value per Share
478.81
473.33
556.77
662.46
644.11
559.44
538.34
1,660.79
1,590.43
1,865.42
2,065.38
2,209.83
2,112.29
2,396.69
1,284.67
- -
1,150.7
Tangible Book Value per Share
31
32
32
32
32
32
32
34
35
35
35
35
35
35
35
- -
35
Basic Weighted Avg Shares
129,387
142,791
154,561
170,226
187,905
234,844
248,110
268,385
275,596
292,615
297,305
316,247
358,742
399,824
456,804
- -
206,097
Sales/Revenue/Turnover
8.09
7.18
6.28
5.94
6.09
6.23
5.87
7.31
5.83
5.49
3.68
4.79
4.46
5.11
3.7
- -
5.67
Operating Margin (%)
2,534
3,013
3,997
4,292
4,832
6,197
7,342
7,533
8,086
8,444
8,679
8,925
9,839
10,885
14,168
- -
- -
Depreciation Expense
3,917
4,899
5,075
5,259
6,197
7,917
7,949
10,567
9,029
9,179
6,697
7,092
9,234
11,401
9,261
- -
6,144
Net Income, GAAP
48.74
49.89
47.72
48.05
42.2
42.93
44.39
41.02
42.01
42.24
43.16
45.9
41.8
40.2
44.51
- -
36.13
Effective Tax Rate (%)
3.03
3.43
3.28
3.09
3.3
3.37
3.2
3.94
3.28
3.14
2.25
2.24
2.57
2.85
2.03
- -
2.98
Profit Margin (%)
416
-2,625
-2,524
-6,015
-8,067
-10,152
-7,535
24,607
11,702
13,102
22,238
18,960
5,319
7,511
-19,237
- -
-17,820
Working Capital
7,332
6,994
9,272
5,957
8,981
16,053
19,213
12,143
6,386
2,586
8,334
5,824
5,053
3,265
26,574
- -
29,062
LT Debt
29,499
33,746
38,357
42,240
48,047
53,325
60,179
96,731
103,922
111,003
115,837
119,010
126,546
135,411
142,632
- -
136,142
Total Equity
12.88
10.81
9.44
9.11
10.72
11.49
9.56
11
7.78
7.75
4.96
6.26
6.89
8.57
5.63
- -
4.71
Return on Invested Capital (%)
12.17
13.32
11.89
11.09
12
12.7
10.7
12.13
9.52
9.56
6.58
6.56
8.2
9.49
6.56
- -
4.51
Return on Capital (%)
20.57
20.41
17.97
16.16
16.52
18.07
15.7
16.24
11.32
10.55
7.2
7.24
8.86
10.13
7.69
- -
5.38
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Apr'24
Jul'25
Oct'25
ST Debt
3,467
- -
7,526
LT Borrowings
3,227
- -
28,795
LT Finance Leases
38
- -
267
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
- -
35
Market Capitalization
209,726
203,317
176,936

Working Capital

FRC

•

in mil. unless spec.
Apr'24
Jul'25
Oct'25
Total Current Assets
110,743
- -
101,841
Cash, Cash Equivalents & STI
48,611
- -
27,221
Accounts Receivable, Net
15,852
- -
16,947
Inventories
24,644
- -
34,751
Total Current Liabilities
103,232
- -
119,661
Payables & Accruals
- -
- -
- -
ST Debt
3,467
- -
7,526
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
94,654
99,073
102,633
103,464
399,824
2025
- -
- -
- -
- -
456,804
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
60.92
- -
- -
- -
324.64
2025
- -
- -
- -
- -
264.32
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
60
2025
- -
- -
- -
- -
80.66
2026
- -
- -
- -
- -
- -
Similar Companies
Mind Medicine (MindMed) Inc. (MMCWF)
Neuca S.a. (NEU.WA)
Cellid, Co., Ltd. (299660.KQ)
PCI Biotech Holding ASA (0JGL.L)
Camurus AB (CAMRF)
Sundrug Co.,Ltd. (SDGCF)
Business
Ain Holdings Inc. operates Japan's leading dispensing pharmacy business alongside a unique retail business encompassing cosmetics and interior furnishing stores. Its core products and services include prescription drug dispensing across more than 1,200 pharmacies nationwide; wholesale of generic drugs; pharmacy staffing and consulting services; retail sales of cosmetics through its ainz & tulpe brand targeting urban female consumers; and operation of Francfranc stores offering interior goods and lifestyle sundries. Founded in 1969 and headquartered in Japan, Ain Holdings also engages in real estate rental strategies. The company recently expanded its pharmacy network significantly by acquiring rival Kraft, operator of the Sakura pharmacy chain, in a transaction valued at over 100 billion yen (approximately $690 million), strengthening its position in the prescription-filling sector amid healthcare market shifts. Ain Holdings operates over 1,550 stores including 1,290 dispensing pharmacies, 95 cosmetics outlets, and 165 furnishing stores, and employs around 18,300 staff including 6,786 pharmacists, making it a major healthcare and retail player across Japan. The company adapts to industry changes such as deregulation and online pharmaceutical guidance while emphasizing cooperation with healthcare professionals to support local healthcare services and promote beauty and lifestyle improvements through its retail brands. This combination of pharmacy and retail operations reflects a diversified business model anchored in healthcare provision and consumer lifestyle enhancement. Recent financial performance includes net sales of ¥456.8 billion and operating profit of ¥16.9 billion for the fiscal year ending April 2025. Ain Holdings is listed on the Tokyo Stock Exchange Prime Market and the Sapporo Securities Exchange.